{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:24:15Z","timestamp":1791923055790,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"34","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,9,8]]},"DOI":"10.1038\/s41388-026-03903-9","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T08:07:15Z","timestamp":1784534835000},"page":"3554-3571","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["YME1L1 degradation by TRIM21 inhibits bladder cancer proliferation, metastasis, and mitochondrial function"],"prefix":"10.1038","volume":"45","author":[{"given":"Long","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwei","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5457-885X","authenticated-orcid":false,"given":"Xiaolong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"3903_CR1","doi-asserted-by":"publisher","first-page":"e076743","DOI":"10.1136\/bmj-2023-076743","volume":"384","author":"A Lopez-Beltran","year":"2024","unstructured":"Lopez-Beltran A, Cookson MS, Guercio BJ, Cheng L. Advances in diagnosis and treatment of bladder cancer. Bmj. 2024;384:e076743.","journal-title":"Bmj"},{"key":"3903_CR2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41571-023-00744-3","volume":"20","author":"LMC van Hoogstraten","year":"2023","unstructured":"van Hoogstraten LMC, Vrieling A, van der Heijden AG, Kogevinas M, Richters A, Kiemeney LA. Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice. Nat Rev Clin Oncol. 2023;20:287\u2013304.","journal-title":"Nat Rev Clin Oncol"},{"key":"3903_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskj\u00f8t","year":"2023","unstructured":"Dyrskj\u00f8t L, Hansel DE, Efstathiou JA, Knowles MA, Galsky MD, Teoh J, et al. Bladder cancer. Nat Rev Dis Primers. 2023;9:58.","journal-title":"Nat Rev Dis Primers"},{"key":"3903_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrc3817","volume":"15","author":"MA Knowles","year":"2015","unstructured":"Knowles MA, Hurst CD. Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity. Nat Rev Cancer. 2015;15:25\u201341.","journal-title":"Nat Rev Cancer"},{"key":"3903_CR5","doi-asserted-by":"publisher","first-page":"e683","DOI":"10.1016\/S1470-2045(18)30693-4","volume":"19","author":"DT Miyamoto","year":"2018","unstructured":"Miyamoto DT, Mouw KW, Feng FY, Shipley WU, Efstathiou JA. Molecular biomarkers in bladder preservation therapy for muscle-invasive bladder cancer. Lancet Oncol. 2018;19:e683\u2013e695.","journal-title":"Lancet Oncol"},{"key":"3903_CR6","doi-asserted-by":"publisher","first-page":"e2409425","DOI":"10.1002\/advs.202409425","volume":"12","author":"Y Lv","year":"2025","unstructured":"Lv Y, Song B, Yang G, Wang Y, Wu Z, Si M, et al. In situ transformable nanoparticle effectively suppresses bladder cancer by damaging mitochondria and blocking mitochondrial autophagy flux. Adv Sci. 2025;12:e2409425.","journal-title":"Adv Sci"},{"key":"3903_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jconrel.2023.09.024","volume":"363","author":"Q Ding","year":"2023","unstructured":"Ding Q, Tang W, Li X, Ding Y, Chen X, Cao W, et al. Mitochondrial-targeted brequinar liposome boosted mitochondrial-related ferroptosis for promoting checkpoint blockade immunotherapy in bladder cancer. J Control Release. 2023;363:221\u201334.","journal-title":"J Control Release"},{"key":"3903_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2026.101458","volume":"108","author":"KM Abdullah","year":"2026","unstructured":"Abdullah KM, Sharma G, Anjum B, Alam MF, Yadav S, Singh Y, et al. Insulin resistance: The central node of convergence between unfolded protein response, diabetes, and cancer. Mol Asp Med. 2026;108:101458.","journal-title":"Mol Asp Med"},{"key":"3903_CR9","doi-asserted-by":"publisher","first-page":"eaba6110","DOI":"10.1126\/scitranslmed.aba6110","volume":"13","author":"B Oresta","year":"2021","unstructured":"Oresta B, Pozzi C, Braga D, Hurle R, Lazzeri M, Colombo P, et al. Mitochondrial metabolic reprogramming controls the induction of immunogenic cell death and efficacy of chemotherapy in bladder cancer. Sci Transl Med. 2021;13:eaba6110.","journal-title":"Sci Transl Med"},{"key":"3903_CR10","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1158\/0008-5472.CAN-15-0491","volume":"75","author":"A Viale","year":"2015","unstructured":"Viale A, Corti D, Draetta GF. Tumors and mitochondrial respiration: a neglected connection. Cancer Res. 2015;75:3685\u20136.","journal-title":"Cancer Res"},{"key":"3903_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1147095","volume":"11","author":"D Zhou","year":"2023","unstructured":"Zhou D, Sun MH, Jiang WJ, Li XH, Lee SH, Heo G, et al. Knock-down of YME1L1 induces mitochondrial dysfunction during early porcine embryonic development. Front Cell Dev Biol. 2023;11:1147095.","journal-title":"Front Cell Dev Biol"},{"key":"3903_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24619-2","volume":"12","author":"J He","year":"2021","unstructured":"He J, Shangguan X, Zhou W, Cao Y, Zheng Q, Tu J, et al. Glucose limitation activates AMPK coupled SENP1-Sirt3 signalling in mitochondria for T cell memory development. Nat Commun. 2021;12:4371.","journal-title":"Nat Commun"},{"key":"3903_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202412233","volume":"12","author":"W Xin","year":"2025","unstructured":"Xin W, Zhou J, Peng Y, Gong S, Liao W, Wang Y, et al. SREBP1c-mediated transcriptional repression of YME1L1 contributes to acute kidney injury by inducing mitochondrial dysfunction in tubular epithelial cells. Adv Sci. 2025;12:e2412233.","journal-title":"Adv Sci"},{"key":"3903_CR14","doi-asserted-by":"publisher","first-page":"7586","DOI":"10.7150\/thno.78616","volume":"12","author":"YZ Guo","year":"2022","unstructured":"Guo YZ, Chen G, Huang M, Wang Y, Liu YY, Jiang Q, et al. TIMM44 is a potential therapeutic target of human glioma. Theranostics. 2022;12:7586\u2013602.","journal-title":"Theranostics"},{"key":"3903_CR15","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.7150\/ijbs.82217","volume":"19","author":"Y Xia","year":"2023","unstructured":"Xia Y, He C, Hu Z, Wu Z, Hui Y, Liu YY, et al. The mitochondrial protein YME1 Like 1 is important for non-small cell lung cancer cell growth. Int J Biol Sci. 2023;19:1778\u201390.","journal-title":"Int J Biol Sci"},{"key":"3903_CR16","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41586-019-1738-6","volume":"575","author":"T MacVicar","year":"2019","unstructured":"MacVicar T, Ohba Y, Nolte H, Mayer FC, Tatsuta T, Sprenger HG, et al. Lipid signalling drives proteolytic rewiring of mitochondria by YME1L. Nature. 2019;575:361\u20135.","journal-title":"Nature"},{"key":"3903_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06722-6","volume":"15","author":"X Sun","year":"2024","unstructured":"Sun X, Shi C, Dai J, Zhang MQ, Pei DS, Yang L. Targeting the mitochondrial protein YME1L to inhibit osteosarcoma cell growth in vitro and in vivo. Cell Death Dis. 2024;15:346.","journal-title":"Cell Death Dis"},{"key":"3903_CR18","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nrc3983","volume":"15","author":"W Kolch","year":"2015","unstructured":"Kolch W, Halasz M, Granovskaya M, Kholodenko BN. The dynamic control of signal transduction networks in cancer cells. Nat Rev Cancer. 2015;15:515\u201327.","journal-title":"Nat Rev Cancer"},{"key":"3903_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev-cellbio-100617-062802","volume":"34","author":"E Oh","year":"2018","unstructured":"Oh E, Akopian D, Rape M. Principles of ubiquitin-dependent signaling. Annu Rev Cell Dev Biol. 2018;34:137\u201362.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"3903_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02046-3","volume":"23","author":"F Liu","year":"2024","unstructured":"Liu F, Chen J, Li K, Li H, Zhu Y, Zhai Y, et al. Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches. Mol Cancer. 2024;23:148.","journal-title":"Mol Cancer"},{"key":"3903_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202501017","volume":"12","author":"Y Tong","year":"2025","unstructured":"Tong Y, Wang Z, Wang Y, Chen Y, Zhang H, Lu Y, et al. The E3 ubiquitin ligase ARIH1 facilitates colorectal cancer progression by promoting oxidative phosphorylation via the mitochondrial translocation of K63-linked ubiquitinated PHB1. Adv Sci. 2025;12:e2501017.","journal-title":"Adv Sci"},{"key":"3903_CR22","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1126\/science.ade5750","volume":"379","author":"M Hunkeler","year":"2023","unstructured":"Hunkeler M, Jin CY, Fischer ES. Structures of BIRC6-client complexes provide a mechanism of SMAC-mediated release of caspases. Science. 2023;379:1105\u201311.","journal-title":"Science"},{"key":"3903_CR23","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.7150\/thno.42874","volume":"10","author":"T Li","year":"2020","unstructured":"Li T, Li Y, Liu T, Hu B, Li J, Liu C, et al. Mitochondrial PAK6 inhibits prostate cancer cell apoptosis via the PAK6-SIRT4-ANT2 complex. Theranostics. 2020;10:2571\u201386.","journal-title":"Theranostics"},{"key":"3903_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58807-1","volume":"16","author":"J Dudley-Fraser","year":"2025","unstructured":"Dudley-Fraser J, Esposito D, McPhie KA, Morley-Williams C, Auchynnikava T, Rittinger K. Identification of RING E3 pseudoligases in the TRIM protein family. Nat Commun. 2025;16:3456.","journal-title":"Nat Commun"},{"key":"3903_CR25","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.3390\/cancers17142367","volume":"17","author":"Y Yamada","year":"2025","unstructured":"Yamada Y, Kimura N, Maki K, Hakozaki Y, Urabe F, Kimura S, et al. The roles of tripartite motif proteins in urological cancers: a systematic review. Cancers. 2025;17:2367.","journal-title":"Cancers"},{"key":"3903_CR26","doi-asserted-by":"publisher","first-page":"e2413674","DOI":"10.1002\/advs.202413674","volume":"12","author":"X Fan","year":"2025","unstructured":"Fan X, Dai Y, Mo C, Li H, Luan X, Wang B, et al. TRIM21 promotes tumor growth and gemcitabine resistance in pancreatic cancer by inhibiting EPHX1-mediated arachidonic acid metabolism. Adv Sci. 2025;12:e2413674.","journal-title":"Adv Sci"},{"key":"3903_CR27","doi-asserted-by":"publisher","first-page":"e164354","DOI":"10.1172\/JCI164354","volume":"133","author":"J Liu","year":"2023","unstructured":"Liu J, Zhang C, Xu D, Zhang T, Chang CY, Wang J, et al. The ubiquitin ligase TRIM21 regulates mutant p53 accumulation and gain of function in cancer. J Clin Investig. 2023;133:e164354.","journal-title":"J Clin Investig"},{"key":"3903_CR28","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1093\/nar\/gkac011","volume":"50","author":"X Zhu","year":"2022","unstructured":"Zhu X, Xue J, Jiang X, Gong Y, Gao C, Cao T, et al. TRIM21 suppresses CHK1 activation by preferentially targeting CLASPIN for K63-linked ubiquitination. Nucleic Acids Res. 2022;50:1517\u201330.","journal-title":"Nucleic Acids Res"},{"key":"3903_CR29","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.62347\/TECQ5002","volume":"14","author":"D Yao","year":"2024","unstructured":"Yao D, Xin F, He X. RNF26-mediated ubiquitination of TRIM21 promotes bladder cancer progression. Am J Cancer Res. 2024;14:4082\u201395.","journal-title":"Am J Cancer Res"},{"key":"3903_CR30","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1111\/cas.13963","volume":"110","author":"YS Tsai","year":"2019","unstructured":"Tsai YS, Jou YC, Tsai HT, Shiau AL, Wu CL, Tzai TS. Prothymosin-\u03b1 enhances phosphatase and tensin homolog expression and binds with tripartite motif-containing protein 21 to regulate Kelch-like ECH-associated protein 1\/nuclear factor erythroid 2-related factor 2 signaling in human bladder cancer. Cancer Sci. 2019;110:1208\u201319.","journal-title":"Cancer Sci"},{"key":"3903_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102201","volume":"48","author":"WS Wei","year":"2021","unstructured":"Wei WS, Wang N, Deng MH, Dong P, Liu JY, Xiang Z, et al. LRPPRC regulates redox homeostasis via the circANKHD1\/FOXM1 axis to enhance bladder urothelial carcinoma tumorigenesis. Redox Biol. 2021;48:102201.","journal-title":"Redox Biol"},{"key":"3903_CR32","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41422-019-0195-y","volume":"29","author":"J Peng","year":"2019","unstructured":"Peng J, Sun BF, Chen CY, Zhou JY, Chen YS, Chen H, et al. Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma. Cell Res. 2019;29:725\u201338.","journal-title":"Cell Res"},{"key":"3903_CR33","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.21873\/anticanres.18052","volume":"46","author":"SN Yamashita","year":"2026","unstructured":"Yamashita SN, Tanaka Y, Islam S, Kitagawa T, Tokuda K, Paudel D, et al. Expression of YME1 like 1 ATPase increases with the stage of adrenocortical carcinoma tissue and is associated with poor patient prognosis. Anticancer Res. 2026;46:1577\u201382.","journal-title":"Anticancer Res"},{"key":"3903_CR34","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1083\/jcb.201308006","volume":"204","author":"R Anand","year":"2014","unstructured":"Anand R, Wai T, Baker MJ, Kladt N, Schauss AC, Rugarli E, et al. The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission. J Cell Biol. 2014;204:919\u201329.","journal-title":"J Cell Biol"},{"key":"3903_CR35","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/mc.22997","volume":"58","author":"K Ando","year":"2019","unstructured":"Ando K, Yokochi T, Mukai A, Wei G, Li Y, Kramer S, et al. Tumor suppressor KIF1B\u03b2 regulates mitochondrial apoptosis in collaboration with YME1L1. Mol Carcinog. 2019;58:1134\u201344.","journal-title":"Mol Carcinog"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03903-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03903-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03903-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:05:23Z","timestamp":1787004323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03903-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":35,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2026,9,8]]}},"alternative-id":["3903"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03903-9","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"26 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}